Editas Medicine Inc (EDIT) has gained Tuesday morning, with the stock adding 2.06% in pre-market trading to 59.4. EDIT's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Editas Medicine Inc ranks higher than 87% of stocks. Editas Medicine Inc has fallen 3.61% over the past month, closing at $64.72 on August 24. During this period of time, the stock fell as low as $58.20 and as high as $73.03. EDIT has an average analyst recommendation of Buy. The company has an average price target of $57.44.
EDIT has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on EDIT!